Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.

Ninomiya Y, Miyamoto S, Tenjin T, Ogino S, Miyake N, Kaneda Y, Sumiyoshi T, Yamaguchi N

Open source

DOI
10.1111/pcn.12202
Published
2014 Dec
Container
Psychiatry and clinical neurosciences
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/pcn.12202,
  title = {Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.},
  author = {Ninomiya Y and Miyamoto S and Tenjin T and Ogino S and Miyake N and Kaneda Y and Sumiyoshi T and Yamaguchi N},
  year = {2014},
  journal = {Psychiatry and clinical neurosciences},
  doi = {10.1111/pcn.12202},
  url = {https://doi.org/10.1111/pcn.12202}
}

RIS

TY  - JOUR
TI  - Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.
AU  - Ninomiya Y
AU  - Miyamoto S
AU  - Tenjin T
AU  - Ogino S
AU  - Miyake N
AU  - Kaneda Y
AU  - Sumiyoshi T
AU  - Yamaguchi N
PY  - 2014
JO  - Psychiatry and clinical neurosciences
DO  - 10.1111/pcn.12202
UR  - https://doi.org/10.1111/pcn.12202
ER  - 

APA

Y, N., S, M., T, T., S, O., N, M., Y, K., T, S., & N, Y. (2014). Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.. Psychiatry and clinical neurosciences. https://doi.org/10.1111/pcn.12202

Source records